Exhibit 99.1

                       Press Release dated March 16, 2005


Sangui sells first quantity of anti-cellulite gel


Witten, Germany, March 16, 2005 - SanguiBioTech GmbH sold an initial quantity of
it's anti-cellulite gel to a German cosmetics distributor at a price of
approximately $ 35,000. The distributor intends to offer the preparation in
German TV shop programmes under his own brand name. Sales are expected to
commence early/mid April.

Sangui's anti-cellulite gel obtained premium results in recent tests with
several groups of probands carried out by Dermatest, a renowned independent
cosmetics research institute headquartered in Muenster, Germany. Skin elasticity
improved over 40% in average in four weeks treatments and up to 61,5% in longer
term treatments.

SanguiBioTech GmbH is a wholly owned subsidiary of Sangui BioTech International,
Inc. (www.pinksheets.com: SGBI)


For more information please contact:

Joachim Fleing
Phone: +49 (160) 741 27 17
Fax: +49 (2302) 915 191
e-mail: fleing@sangui.de


Some of the statements contained in this news release discuss future
expectations, contain projections of results of operation or financial condition
or state other "forward-looking" information. These statements are subject to
known and unknown risks, uncertainties, and other factors that could cause the
actual results to differ materially from those contemplated by the statements.
The forward-looking information is based on various factors and is derived using
numerous assumptions. Important factors that may cause actual results to differ
from projections include, among many others, the ability of the Company to raise
sufficient capital to meet operating requirements. Words such as "anticipates,"
"expects," "intends," "plans," "believes," "seeks," "estimates," and variations
of such words and similar expressions are intended to identify such
forward-looking statements. Unless required by law, the Company undertakes no
obligation to update publicly any forward-looking statements, whether as a
result of new information, future events or otherwise.